Trial ChiCTR2000029972
Publication Huang L, medRxiv, 2021
Primary outcome on the report: 1) The length of recovery from symptoms measured by seven-category ordinal, systemic inflammatory response syndrome (SIRS) scale; 2) negative conversion rate of the SARS-CoV-2 nucleic acid test by reverse transcription PCR (RT-PCR), after 7, 14, 21, and 28 days of treatment.

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.